Matthew Feinsod is a Long Island City, New York based male Ophthalmologist who is specialized in Ophthalmology. Active license number of Matthew Feinsod is 208244 for Ophthalmology in New York. Matthew Feinsod is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Matthew Feinsod speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
MD
Gender:
Male
Practice Address:
3711 Queens Blvd, Long Island City, New York, 11101-1725
Phone:
718-361-5100
Fax:
718-729-2849
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1972800829
NPI Enumeration Date:
11 Feb, 2011
NPI Last Update On:
11 Feb, 2011
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Matthew Feinsod are as mentioned below.
License Number
Specialization
State
Status
208244
Ophthalmology
New York
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
4 Nassau Dr, Great Neck, New York
Zip:
11021-1248
Phone Number:
--
Fax Number:
--
Patients can reach Matthew Feinsod at 3711 Queens Blvd, Long Island City, New York or can call to book an appointment on 718-361-5100. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.